Accumulating evidence for a role of oxidized phospholipids in infectious diseases

Cellular and Molecular Life Sciences

Volumn 72, Issue 6, 2015, Pages 1059-1071

  Matt, Ulrich ^a   Sharif, Omar ^b,c   Martins, Rui ^b,c   Knapp, Sylvia ^b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Danger associated molecular patterns; Infectious diseases; Innate immunity; Oxidized phospholipids

Indexed keywords

1 PALMITOYL 2 (5 OXOVALEROYL) SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 (5,6) EPOXYISOPROSTANE E2 SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 ARACHIDONOYL SN PHOSPHATIDYLCHOLINE; OXIDIZED 1 PALMITOYL 2 ARACHIDONOYL SN PHOSPHATIDYLCHOLINE; OXIDIZED PHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL PERITONITIS; CELL FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LEPROSY; LIPID ANALYSIS; LIPID METABOLISM; MASS SPECTROMETRY; MONKEYPOX VIRUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NONHUMAN; PATHOGENESIS; PNEUMONIA; SARS CORONAVIRUS; SIGNAL TRANSDUCTION; YERSINIA PESTIS; ANIMAL; BACTERIAL INFECTION; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; OXIDATION REDUCTION REACTION; PERITONITIS; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; OXIDATION-REDUCTION; PERITONITIS; PHOSPHOLIPIDS; REACTIVE OXYGEN SPECIES; VIRUS DISEASES;

EID: 84925539142     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1780-3     Document Type: Article

References (111)

1. Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, Hartvigsen K, Boullier A, Gonen A, Diehl CJ, Que X, Montano E, Shaw PX, Tsimikas S, Binder CJ, Witztum JL (2011) Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 108(2):235-248
2. Weismann D, Binder CJ (2012) The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta 1818 10:2465-2475
3. Lee S, Birukov KG, Romanoski CE, Springstead JR, Lusis AJ, Berliner JA (2012) Role of phospholipid oxidation products in atherosclerosis. Circ Res 111(6):778-799
4. Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92(9):3007-3017
5. Babior BM (2000) Phagocytes and oxidative stress. Am J Med 109(1):33-44
6. Bochkov VN, Kadl A, Huber J, Gruber F, Binder BR, Leitinger N (2002) Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419(6902):77-81
7. Matt U, Sharif O, Martins R, Furtner T, Langeberg L, Gawish R, Elbau I, Zivkovic A, Lakovits K, Oskolkova O, Doninger B, Vychytil A, Perkmann T, Schabbauer G, Binder CJ, Bochkov VN, Scott JD, Knapp S (2013) WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. J Clin Investig 123(7):3014-3024
8. Bluml S, Rosc B, Lorincz A, Seyerl M, Kirchberger S, Oskolkova O, Bochkov VN, Majdic O, Ligeti E, Stockl J (2008) The oxidation state of phospholipids controls the oxidative burst in neutrophil granulocytes. J Immunol 181(6):4347-4353
9. Ikeda M, Kihara A, Igarashi Y (2006) Lipid asymmetry of the eukaryotic plasma membrane: functions and related enzymes. Biol Pharm Bull 29(8):1542-1546
10. Zhang R, Shen Z, Nauseef WM, Hazen SL (2002) Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma. Blood 99(5):1802-1810
11. Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, Stockl J (2010) Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 12(8):1009-1059
12. Bochkov VN (2007) Inflammatory profile of oxidized phospholipids. Thromb Haemost 97(3):348-354
13. Greenberg ME, Li XM, Gugiu BG, Gu X, Qin J, Salomon RG, Hazen SL (2008) The lipid whisker model of the structure of oxidized cell membranes. J Biol Chem 283(4):2385-2396
14. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272(21):13597-13607
15. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA (2000) Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol 20(10):2248-2254
16. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL (2002) A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem 277(41):38517-38523
17. Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41(3):360-370
18. Yoshimi N, Ikura Y, Sugama Y, Kayo S, Ohsawa M, Yamamoto S, Inoue Y, Hirata K, Itabe H, Yoshikawa J, Ueda M (2005) Oxidized phosphatidylcholine in alveolar macrophages in idiopathic interstitial pneumonias. Lung 183(2):109-121
19. Nakamura T, Henson PM, Murphy RC (1998) Occurrence of oxidized metabolites of arachidonic acid esterified to phospholipids in murine lung tissue. Anal Biochem 262(1):23-32
20. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133(2):235-249
21. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, Kurokawa K (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Investig 100(12):2995-3004
22. Houglum K, Ramm GA, Crawford DH, Witztum JL, Powell LW, Chojkier M (1997) Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis. Hepatology 26(3):605-610
23. Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, Binder BR, Leitinger N (2002) Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 22(1):101-107
24. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Backhed F, Miller YI, Horkko S, Corr M, Witztum JL, Binder CJ (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Investig 119(5):1335-1349
25. Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, Witztum JL (2004) Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 200(11):1359-1370
26. Subbanagounder G, Wong JW, Lee H, Faull KF, Miller E, Witztum JL, Berliner JA (2002) Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. J Biol Chem 277(9):7271-7281
27. Newcombe J, Li H, Cuzner ML (1994) Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20(2):152-162
28. Dei R, Takeda A, Niwa H, Li M, Nakagomi Y, Watanabe M, Inagaki T, Washimi Y, Yasuda Y, Horie K, Miyata T, Sobue G (2002) Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol 104(2):113-122
29. Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Investig 98(3):800-814
30. Friedman P, Horkko S, Steinberg D, Witztum JL, Dennis EA (2002) Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation. J Biol Chem 277(9):7010-7020
31. Gillotte-Taylor K, Boullier A, Witztum JL, Steinberg D, Quehenberger O (2001) Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res 42(9):1474-1482
32. Boullier A, Friedman P, Harkewicz R, Hartvigsen K, Green SR, Almazan F, Dennis EA, Steinberg D, Witztum JL, Quehenberger O (2005) Phosphocholine as a pattern recognition ligand for CD36. J Lipid Res 46(5):969-976
33. Pegorier S, Stengel D, Durand H, Croset M, Ninio E (2006) Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. Atherosclerosis 188(2):433-443
34. Li R, Mouillesseaux KP, Montoya D, Cruz D, Gharavi N, Dun M, Koroniak L, Berliner JA (2006) Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ Res 98(5):642-650
35. Walton KA, Hsieh X, Gharavi N, Wang S, Wang G, Yeh M, Cole AL, Berliner JA (2003) Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem 278(32):29661-29666
36. Kadl A, Sharma PR, Chen W, Agrawal R, Meher AK, Rudraiah S, Grubbs N, Sharma R, Leitinger N (2011) Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. Free Radic Biol Med 51(10):1903-1909
37. Monaco C (2012) The tolls and dangers of atherosclerotic disease. Curr Pharm Biotechnol 13(1):77-87
38. Nilsen NJ, Deininger S, Nonstad U, Skjeldal F, Husebye H, Rodionov D, von Aulock S, Hartung T, Lien E, Bakke O, Espevik T (2008) Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J Leukoc Biol 84(1):280-291
39. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B (2005) CD36 is a sensor of diacylglycerides. Nature 433(7025):523-527
40. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11(2):155-161
41. Erridge C, Kennedy S, Spickett CM, Webb DJ (2008) Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J Biol Chem 283(36):24748-24759. doi: 10.1074/jbc.M800352200
42. Kim MJ, Choi NY, Koo JE, Kim SY, Joung SM, Jeong E, Lee JY (2013) Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2. Inflamm Res 62(6):571-580. doi: 10.1007/s00011-013-0609-0
43. Ma Z, Li J, Yang L, Mu Y, Xie W, Pitt B, Li S (2004) Inhibition of LPS-and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 286(4):L808-L816
44. Arthur JS, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13(9):679-692
45. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8(1):49-62
46. Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK (2003) Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler Thromb Vasc Biol 23(8):1384-1390
47. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N (2003) Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 278(51):51006-51014
48. Parry GC, Mackman N (1997) Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol 159(11):5450-5456
49. Takahashi N, Tetsuka T, Uranishi H, Okamoto T (2002) Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur J Biochem 269(18):4559-4565
50. Knapp S, Matt U, Leitinger N, van der Poll T (2007) Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J Immunol 178(2):993-1001
51. Hall A (2005) Rho GTPases and the control of cell behaviour. Biochem Soc Trans 33(Pt 5):891-895
52. Birukov KG, Bochkov VN, Birukova AA, Kawkitinarong K, Rios A, Leitner A, Verin AD, Bokoch GM, Leitinger N, Garcia JG (2004) Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res 95(9):892-901
53. Rouhanizadeh M, Hwang J, Clempus RE, Marcu L, Lassegue B, Sevanian A, Hsiai TK (2005) Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic Biol Med 39(11):1512-1522
54. Smith RM, Curnutte JT (1991) Molecular basis of chronic granulomatous disease. Blood 77(4):673-686
55. Chicco AJ, Sparagna GC (2007) Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292(1):C33-C44. doi: 10.1152/ajpcell.00243.2006
56. Wallgren M, Lidman M, Pham QD, Cyprych K, Grobner G (2012) The oxidized phospholipid PazePC modulates interactions between Bax and mitochondrial membranes. Biochim Biophys Acta 1818 11:2718-2724. doi: 10.1016/j.bbamem.2012.06.005
57. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, Eisenbarth SC, Nauseef WM, Cassel SL, Sutterwala FS (2013) Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39(2):311-323. doi: 10.1016/j.immuni.2013.08.001
58. Lamkanfi M, Dixit VM (2014) Mechanisms and functions of inflammasomes. Cell 157(5):1013-1022. doi: 10.1016/j.cell.2014.04.007
59. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA, Moore KJ (2013) CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14(8):812-820. doi: 10.1038/ni.2639
60. Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, van der Poll T (2002) Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 282(2):L285-L290. doi: 10.1152/ajplung.00461.2000
61. Mason MJ, Van Epps DE (1989) In vivo neutrophil emigration in response to interleukin-1 and tumor necrosis factor-alpha. J Leukoc Biol 45(1):62-68
62. Cybulsky MI, Colditz IG, Movat HZ (1986) The role of interleukin-1 in neutrophil leukocyte emigration induced by endotoxin. Am J Pathol 124(3):367-372
63. Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, van der Poll T (2001) TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 167(9):5240-5246
64. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17(2):179-188. doi: 10.1038/nm.2279
65. Halasiddappa LM, Koefeler H, Futerman AH, Hermetter A (2013) Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: role of ceramide synthases. PLoS ONE 8(7):e70002. doi: 10.1371/journal.pone.0070002
66. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360(9328):219-223. doi: 10.1016/S0140-6736(02)09459-X
67. Ruggieri AJ, Levy RJ, Deutschman CS (2010) Mitochondrial dysfunction and resuscitation in sepsis. Crit Care Clin 26(3):567-575. doi: 10.1016/j.ccc.2010.04.007
68. Bluml S, Kirchberger S, Bochkov VN, Kronke G, Stuhlmeier K, Majdic O, Zlabinger GJ, Knapp W, Binder BR, Stockl J, Leitinger N (2005) Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 175(1):501-508
69. Bluml S, Zupkovitz G, Kirchberger S, Seyerl M, Bochkov VN, Stuhlmeier K, Majdic O, Zlabinger GJ, Seiser C, Stockl J (2009) Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids. Blood 114(27):5481-5489
70. Wen H, Dou Y, Hogaboam CM, Kunkel SL (2008) Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 111(4):1797-1804
71. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ (2001) Sepsis-induced immunosuppression: from bad to worse. Immunol Res 24(3):273-287
72. Chroneos ZC, Sever-Chroneos Z, Shepherd VL (2010) Pulmonary surfactant: an immunological perspective. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 25(1):13-26
73. Kuzmenko AI, Wu H, Bridges JP, McCormack FX (2004) Surfactant lipid peroxidation damages surfactant protein A and inhibits interactions with phospholipid vesicles. J Lipid Res 45(6):1061-1068
74. Rahman I, MacNee W (2000) Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16(3):534-554
75. Cho YS, Moon HB (2010) The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res 2(3):183-187
76. Yao H, Rahman I (2011) Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol 254(2):72-85
77. Galli F, Battistoni A, Gambari R, Pompella A, Bragonzi A, Pilolli F, Iuliano L, Piroddi M, Dechecchi MC, Cabrini G, Working Group on Inflammation in Cystic Fibrosis (2012) Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim Biophys Acta 1822 5:690-713
78. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W (1996) Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153(1):176-184
79. Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A (2007) Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res 8:55
80. Wang Y, Manevich Y, Feinstein SI, Fisher AB (2004) Adenovirus-mediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 286(6):L1188-L1193
81. Manevich Y, Fisher AB (2005) Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 38(11):1422-1432
82. Uhlson C, Harrison K, Allen CB, Ahmad S, White CW, Murphy RC (2002) Oxidized phospholipids derived from ozone-treated lung surfactant extract reduce macrophage and epithelial cell viability. Chem Res Toxicol 15(7):896-906
83. Kafoury RM, Pryor WA, Squadrito GL, Salgo MG, Zou X, Friedman M (1999) Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. Am J Respir Crit Care Med 160(6):1934-1942
84. Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, Kobzik L (2007) Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Investig 117(3):757-764
85. Chang MK, Binder CJ, Torzewski M, Witztum JL (2002) C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 99(20):13043-13048
86. Gershov D, Kim S, Brot N, Elkon KB (2000) C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192(9):1353-1364
87. Suresh MV, Singh SK, Ferguson DA Jr, Agrawal A (2007) Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide. Journal of immunology 178(2):1158-1163
88. Heuertz RM, Piquette CA, Webster RO (1993) Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol 142(1):319-328
89. Webster RO, Heuertz R, Xia D, Samols D (1994) Attenuation of complement-mediated acute lung injury in rabbits and transgenic mice by C-reactive protein. Chest 105(3 Suppl):101S
90. Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, Christiani DC (2009) Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 136(2):471-480
91. Akaike T, Ando M, Oda T, Doi T, Ijiri S, Araki S, Maeda H (1990) Dependence on O2-generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Investig 85(3):739-745
92. Buffinton GD, Christen S, Peterhans E, Stocker R (1992) Oxidative stress in lungs of mice infected with influenza A virus. Free Radic Res Commun 16(2):99-110
93. Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J, Chen WH, Ernst RK, Rossignol DP, Gusovsky F, Blanco JC, Vogel SN (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497(7450):498-502
94. Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hui EK, Nayak DP, Fogelman AM (2004) D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 110(20):3252-3258
95. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM (2001) High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation 103(18):2283-2288
96. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM (2002) Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 106(9):1127-1132
97. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351(25):2611-2618. doi: 10.1056/NEJMoa041747
98. Clayton TC, Thompson M, Meade TW (2008) Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 29(1):96-103. doi: 10.1093/eurheartj/ehm516
99. Lee YH, Lai CL, Hsieh SH, Shieh CC, Huang LM, Wu-Hsieh BA (2013) Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model. Virus Res 178(2):411-422. doi: 10.1016/j.virusres.2013.09.011
100. Matt U, Warszawska JM, Bauer M, Dietl W, Mesteri I, Doninger B, Haslinger I, Schabbauer G, Perkmann T, Binder CJ, Reingruber S, Petzelbauer P, Knapp S (2009) Bbeta(15-42) protects against acid-induced acute lung injury and secondary pseudomonas pneumonia in vivo. Am J Respir Crit Care Med 180(12):1208-1217
101. Thimmulappa RK, Gang X, Kim JH, Sussan TE, Witztum JL, Biswal S (2012) Oxidized phospholipids impair pulmonary antibacterial defenses: evidence in mice exposed to cigarette smoke. Biochem Biophys Res Commun 426(2):253-259. doi: 10.1016/j.bbrc.2012.08.076
102. Nonas S, Miller I, Kawkitinarong K, Chatchavalvanich S, Gorshkova I, Bochkov VN, Leitinger N, Natarajan V, Garcia JG, Birukov KG (2006) Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am J Respir Crit Care Med 173(10):1130-1138
103. Birukova AA, Fu P, Chatchavalvanich S, Burdette D, Oskolkova O, Bochkov VN, Birukov KG (2007) Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 292(4):L924-L935
104. Nonas S, Birukova AA, Fu P, Xing J, Chatchavalvanich S, Bochkov VN, Leitinger N, Garcia JG, Birukov KG (2008) Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivo. Crit Care 12(1):R27
105. Birukova AA, Singleton PA, Gawlak G, Tian X, Mirzapoiazova T, Mambetsariev B, Dubrovskyi O, Oskolkova OV, Bochkov VN, Birukov KG (2014) GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids. Mol Biol Cell 25(13):2006-2016
106. Lusis AJ (2000) Atherosclerosis. Nature 407(6801):233-241
107. Walker SL, Lockwood DN (2007) Leprosy. Clin Dermatol 25(2):165-172
108. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254(5029):277-279
109. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, Modlin RL (2008) Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Investig 118(8):2917-2928
110. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768):1770-1773
111. Bova IY, Bornstein NM, Korczyn AD (1996) Acute infection as a risk factor for ischemic stroke. Stroke 27(12):2204-2206